| Dr Barry Jason Derden, PHARM D | |
|
615 Miller Cv, Benton, AR 72019-2399 | |
| (501) 776-0021 | |
| Not Available |
| Full Name | Dr Barry Jason Derden |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 615 Miller Cv, Benton, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184850570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD08477 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barry Jason Derden, PHARM D 615 Miller Cv, Benton, AR 72019-2399 Ph: (501) 776-0021 | Dr Barry Jason Derden, PHARM D 615 Miller Cv, Benton, AR 72019-2399 Ph: (501) 776-0021 |
News Archive
Two demonstration projects that aim to yield quick results for patients have been selected by the new California Initiative to Advance Precision Medicine, a public-private effort launched by Governor Edmund G. Brown Jr.
Chunying Du, Ph.D., Assistant Investigator at the Stowers Institute, has published findings that reveal a previously unknown pathway of Bruce, the gene encoding a protein that inhibits apoptosis, or programmed cell death.
New UMN research recently published Blood Advances, Kalpna Gupta, PhD, Professor of Medicine, University of Minnesota Medical School, demonstrates the impact of opioids on the survival of humanized mouse models with sickle cell disease, compared to normal mice.
The French health authority has revealed that it is rejecting half of all NeeS (non-eCTD electronic submissions) dossiers because they have been poorly formatted and do not meet basic validation standards. This is costing pharmaceutical companies time and money, as they re-work the submission format, and incur delays in getting their submissions reviewed and approved. Two-thirds of all electronic submissions to AFSSAPS currently are in the NeeS format.
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
› Verified 9 days ago
Jana Spivey White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17309 I 30, Benton, AR 72015 Phone: 501-778-5041 Fax: 501-315-5044 | |
Dr. Nick L. Landers, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 414 N Main St, Benton, AR 72015 Phone: 501-315-7700 Fax: 501-315-4136 | |
Sandra Hawn, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Military Rd, Benton, AR 72015 Phone: 501-860-7372 | |
Kristen Leeann Lovelady, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20820 Interstate 30 N, Benton, AR 72019 Phone: 501-574-3884 | |
Dr. Maddison Elaine Schuller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 620 W South St, Benton, AR 72015 Phone: 501-778-3151 | |
Dr. Isabelle Diane Reaves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1016 W South St Ste 1, Benton, AR 72015 Phone: 501-315-5100 Fax: 501-776-1313 | |
Dr. Blake Torres, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 W Sevier St, Benton, AR 72015 Phone: 501-778-3151 |